SRN Advisors LLC Has $1.17 Million Position in The Sherwin-Williams Company (NYSE:SHW)

SRN Advisors LLC cut its stake in shares of The Sherwin-Williams Company (NYSE:SHW) by 4.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,073 shares of the specialty chemicals company’s stock after selling 135 shares during the quarter. SRN Advisors LLC’s holdings in Sherwin-Williams were worth $1,173,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. HHM Wealth Advisors LLC boosted its position in Sherwin-Williams by 102.3% in the second quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 45 shares in the last quarter. Semmax Financial Advisors Inc. boosted its holdings in shares of Sherwin-Williams by 136.4% in the 2nd quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock worth $31,000 after acquiring an additional 60 shares in the last quarter. VitalStone Financial LLC grew its position in Sherwin-Williams by 233.3% during the 2nd quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock worth $33,000 after acquiring an additional 77 shares during the last quarter. GHP Investment Advisors Inc. increased its holdings in Sherwin-Williams by 47.5% during the 3rd quarter. GHP Investment Advisors Inc. now owns 87 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 28 shares in the last quarter. Finally, Anfield Capital Management LLC bought a new position in Sherwin-Williams in the 2nd quarter valued at $38,000. Institutional investors and hedge funds own 77.67% of the company’s stock.

Sherwin-Williams Stock Performance

SHW stock opened at $359.04 on Friday. The Sherwin-Williams Company has a 1-year low of $232.06 and a 1-year high of $392.57. The business’s 50-day moving average price is $372.00 and its two-hundred day moving average price is $335.02. The firm has a market cap of $91.03 billion, a PE ratio of 38.28, a P/E/G ratio of 2.87 and a beta of 1.17. The company has a current ratio of 0.83, a quick ratio of 0.50 and a debt-to-equity ratio of 1.97.

Sherwin-Williams (NYSE:SHW) last released its quarterly earnings data on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share for the quarter, missing the consensus estimate of $3.56 by ($0.19). The business had revenue of $6.16 billion for the quarter, compared to the consensus estimate of $6.20 billion. Sherwin-Williams had a net margin of 11.09% and a return on equity of 74.45%. The company’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter last year, the firm earned $3.20 EPS. As a group, research analysts forecast that The Sherwin-Williams Company will post 11.31 earnings per share for the current year.

Sherwin-Williams Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be given a $0.715 dividend. The ex-dividend date is Friday, November 15th. This represents a $2.86 annualized dividend and a yield of 0.80%. Sherwin-Williams’s dividend payout ratio is currently 30.49%.

Analysts Set New Price Targets

A number of research firms have commented on SHW. Wells Fargo & Company boosted their price objective on Sherwin-Williams from $350.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 15th. KeyCorp reiterated a “sector weight” rating on shares of Sherwin-Williams in a research report on Monday, October 7th. The Goldman Sachs Group raised their price objective on shares of Sherwin-Williams from $344.00 to $390.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. Morgan Stanley upped their target price on shares of Sherwin-Williams from $375.00 to $450.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Finally, UBS Group reissued an “underperform” rating on shares of Sherwin-Williams in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $395.29.

Insider Buying and Selling

In other Sherwin-Williams news, CFO Allen J. Mistysyn sold 14,520 shares of Sherwin-Williams stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $366.83, for a total value of $5,326,371.60. Following the sale, the chief financial officer now owns 63,520 shares of the company’s stock, valued at $23,301,041.60. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.60% of the company’s stock.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.